Cellular Technology Limited
Greg Kirchenbaum has worked at six organizations over the past 15 years. From 2004-2006, they were an Undergraduate Researcher at Florida State University. In 2006, they were a Research Technician at Phoenix Biosciences, Inc. From 2007-2013, they were a Graduate Student at National Jewish Health, followed by a Postdoctoral Research Fellow at VGTI Florida from 2013-2015. From 2015-2018, they worked at the University of Georgia as an Assistant Research Scientist and Postdoctoral Fellow. Since 2018, they have been the Director of Basic B cell Research and Senior Staff Scientist at Cellular Technology Limited (CTL).
Greg Kirchenbaum graduated from Florida State University in 2006 with a Bachelor of Science with Honors in Biology, General. Prior to that, they attended Western High School from 1998 to 2002.
Cellular Technology Limited
Cellular Technology Limited (CTL) has been pioneering the ELISPOT technology for immune monitoring. For nearly 20 years, CTL’s mission has been “Elevating ELISPOT to an Exact Science”. Serving over 2,000 clients from academia and industry worldwide, CTL offers unparalleled expertise in immune monitoring